Polymeric micelles and nanoemulsions as tumor-targeted drug carriers: Insight through intravital imaging

Journal of Controlled Release

Volumn 206, Issue , 2015, Pages 153-160

  Rapoport, Natalya ^a   Gupta, Roohi ^a,c   Kim, Yoo Shin ^b   O'Neill, Brian E ^b  

^a University of Utah   (United States)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

Drug delivery; Intravital microscopy; Micelles; Nanodroplets; Nanoparticle diffusion; Nanoparticle extravasation; Paclitaxel; Perfluorocarbon

Indexed keywords

BLOOD VESSELS; CONTINUUM MECHANICS; DIFFUSION; DRUG DELIVERY; DRUG THERAPY; FLUORESCENCE; MICELLES; NANOPARTICLES; POLYMERS; TUMORS;

CONCENTRATION GRADIENTS; FLUORESCENT MICROSCOPY; INTRAVITAL MICROSCOPY; NANO-DROPLETS; PACLITAXEL; PERFLUOROCARBONS; TISSUE ACCUMULATION; TUMOR ACCUMULATION;

TISSUE;

COPOLYMER; DRUG CARRIER; MACROGOL; PACLITAXEL; POLYLACTIDE; ANTINEOPLASTIC AGENT; MICELLE; NANOPARTICLE; POLYMER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BLOOD VESSEL; CANCER SIZE; CELL DENSITY; CELL ENCAPSULATION; CIRCULATION; CONTROLLED STUDY; DRUG COATING; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG EXTRAVASATION; DRUG MECHANISM; DRUG RESISTANCE; DRUG STABILITY; DRUG TARGETING; FEMALE; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMAGE PROCESSING; INTERNALIZATION; INTRAVITAL FLUORESCENT MICROSCOPY; MICELLE; MOUSE; NANOEMULSION; NONHUMAN; PANCREAS TUMOR; POLYMERIC MICELLE; POLYMERIZATION; PRIORITY JOURNAL; TUMOR CELL; ANIMAL; FLUORESCENCE IMAGING; METABOLISM; MICROSCOPY; NEOPLASM; NUDE MOUSE; TUMOR CELL LINE; VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MICE, NUDE; MICELLES; MICROSCOPY; NANOPARTICLES; NEOPLASMS; OPTICAL IMAGING; PACLITAXEL; POLYMERS;

EID: 84925732898     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.03.010     Document Type: Article

References (48)

1. Y. Matsumura, T. Hamaguchi, T. Ura, K. Muro, Y. Yamada, Y. Shimada, K. Shirao, T. Okusaka, H. Ueno, M. Ikeda, and N. Watanabe Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin Br. J. Cancer 91 2004 1775 1781
2. S. Danson, D. Ferry, V. Alakhov, J. Margison, D. Kerr, D. Jowle, M. Brampton, G. Halbert, and M. Ranson Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer Br. J. Cancer 90 2004 2085 2091
3. D.W. Kim, S.Y. Kim, H.K. Kim, S.W. Kim, S.W. Shin, J.S. Kim, K. Park, M.Y. Lee, and D.S. Heo Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer Ann. Oncol. 18 2007 2009 2014
4. T.Y. Kim, D.W. Kim, J.Y. Chung, S.G. Shin, S.C. Kim, D.S. Heo, N.K. Kim, and Y.J. Bang Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies Clin. Cancer Res. 10 2004 3708 3716
5. T. Hamaguchi, Y. Matsumura, M. Suzuki, K. Shimizu, R. Goda, I. Nakamura, I. Nakatomi, M. Yokoyama, K. Kataoka, and T. Kakizoe NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel Br. J. Cancer 92 2005 1240 1246
6. J.G. Kim, S.K. Sohn, H.S. Song, K.Y. Kwon, Y.R. Do, K.H. Lee, M.S. Hyun, H.M. Ryoo, S.H. Bae, K.U. Park, J.H. Baek, W.S. Lee, J.S. Chung, G.J. Cho, C.H. Sohn, J.S. Jang, H.Y. Chung, and W. Yu Multicenter phase II study of weekly paclitaxel plus cisplatin combination chemotherapy in patients with advanced gastric cancer Cancer Chemother. Pharmacol. 60 2007 863 869
7. S.C. Kim, D.W. Kim, Y.H. Shim, J.S. Bang, H.S. Oh, S. Wan Kim, and M.H. Seo In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy J. Control. Release 72 2001 191 202
8. M.W. Saif, N.A. Podoltsev, M.S. Rubin, J.A. Figueroa, M.Y. Lee, J. Kwon, E. Rowen, J. Yu, and R.O. Kerr Phase II clinical trial of paclitaxel loaded polymeric micelle in patients with advanced pancreatic cancer Cancer Investig. 28 2010 186 194
9. Y. Lu, and K. Park Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs Int. J. Pharm. 453 2013 198 214
10. D.Y. Alakhova, N.Y. Rapoport, E.V. Batrakova, A.A. Timoshin, S. Li, D. Nicholls, V.Y. Alakhov, and A.V. Kabanov Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers J. Control. Release 142 2010 89 100
11. E. Batrakova, S. Lee, S. Li, A. Venne, V. Alakhov, and A. Kabanov Fundamental relationships between the composition of pluronic block copolymers and their hypersensitization effect in MDR cancer cells Pharm. Res. 16 1999 1373 1379
12. E.V. Batrakova, and A.V. Kabanov Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers J. Control. Release 130 2008 98 106
13. E.V. Batrakova, S. Li, A.M. Brynskikh, A.K. Sharma, Y. Li, M. Boska, N. Gong, R.L. Mosley, V.Y. Alakhov, H.E. Gendelman, and A.V. Kabanov Effects of pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers J. Control. Release 143 2010 290 301
14. E.V. Batrakova, S. Li, W.F. Elmquist, D.W. Miller, V.Y. Alakhov, and A.V. Kabanov Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion Br. J. Cancer 85 2001 1987 1997
15. A.V. Kabanov, and V.Y. Alakhov Pluronic block copolymers in drug delivery: from micellar nanocontainers to biological response modifiers Crit. Rev. Ther. Drug Carrier Syst. 19 2002 1 72
16. A.V. Kabanov, E.V. Batrakova, and V.Y. Alakhov Pluronic block copolymers for overcoming drug resistance in cancer Adv. Drug Deliv. Rev. 54 2002 759 779
17. A.V. Kabanov, E.V. Batrakova, and V.Y. Alakhov An essential relationship between ATP depletion and chemosensitizing activity of Pluronic block copolymers J. Control. Release 91 2003 75 83
18. A.V. Kabanov, E.V. Batrakova, and D.W. Miller Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier Adv. Drug Deliv. Rev. 55 2003 151 164
19. S.O. Kim, S.W. Lee, S.W. Jeong, Y.A. Jung, S.Y. Kang, S. Kumar, and H.S. Oh Superior antitumor efficacy of Genexol-PM®, a biodegradable polymeric micelle-based formulation of paclitaxel (Genexol®) compared with Gemzar® (gemcitabine) and Taxol® in human pancreatic cancer cells in vitro and in vivo Experimental and Molecular Therapeutics 10: Drug Targeting Proc Amer Assoc Cancer Res 46 2005 (Abstract 1440)
20. K.S. Lee, H.C. Chung, S.A. Im, Y.H. Park, C.S. Kim, S.B. Kim, S.Y. Rha, M.Y. Lee, and J. Ro Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer Breast Cancer Res. Treat. 108 2008 241 250
21. N. Rapoport Stabilization and acoustic activation of Pluronic micelles for tumor-targeted drug delivery Colloids Surf. B Biointerfaces 3 1999 93 111
22. H.C. Shin, H. Cho, T.C. Lai, K.R. Kozak, J.M. Kolesar, and G.S. Kwon Pharmacokinetic study of 3-in-1 poly(ethylene glycol)-block-poly(d, l-lactic acid) micelles carrying paclitaxel, 17-allylamino-17-demethoxygeldanamycin, and rapamycin J. Control. Release 163 2012 93 99
23. B.E. O'Neill, and N. Rapoport Phase-shift, stimuli-responsive drug carriers for targeted delivery Ther. Deliv. 2 2011 1165 1187
24. N. Rapoport Phase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancer Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 4 2012 492 510
25. N. Rapoport, Z. Gao, and A. Kennedy Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy J. Natl. Cancer Inst. 99 2007 1095 1106
26. N. Rapoport, K.-H. Nam, R. Gupta, Z. Gao, P. Mohan, A. Payne, N. Todd, X. Liu, T. Kim, J. Shea, C. Scaife, A.M. Kennedy, D.L. Parker, and E.-K. Jeong Ultrasound-mediated tumor imaging and nanotherapy using drug loaded, block copolymer stabilized perfluorocarbon nanoemulsions J. Control. Release 153 2011 4 15
27. N. Rapoport, A. Payne, C. Dillon, J. Shea, C. Scaife, and R. Gupta Focused ultrasound-mediated drug delivery to pancreatic cancer in a mouse model J. Ther. Ultrasound 1 2013
28. N.Y. Rapoport, A.M. Kennedy, J.E. Shea, C.L. Scaife, and K.-H. Nam Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles J. Control. Release 138 2009 268 276
29. M.L. Fabiilli, K.J. Haworth, I.E. Sebastian, O.D. Kripfgans, P.L. Carson, and J.B. Fowlkes Delivery of chlorambucil using an acoustically-triggered perfluoropentane emulsion Ultrasound Med. Biol. 36 2010 1364 1375
30. M.L. Fabiilli, J.A. Lee, O.D. Kripfgans, P.L. Carson, and J.B. Fowlkes Delivery of water-soluble drugs using acoustically triggered perfluorocarbon double emulsions Pharm. Res. 27 2010 2753 2765
31. O.D. Kripfgans, J.B. Fowlkes, D.L. Miller, O.P. Eldevik, and P.L. Carson Acoustic droplet vaporization for therapeutic and diagnostic applications Ultrasound Med. Biol. 26 2000 1177 1189
32. N. Rapoport, A.M. Kennedy, J.E. Shea, C.L. Scaife, and K.H. Nam Ultrasonic nanotherapy of pancreatic cancer: lessons from ultrasound imaging Mol. Pharm. 7 2010 22 31
33. J. Wang, D. Mongayt, and V.P. Torchilin Polymeric micelles for delivery of poorly soluble drugs: preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipids J. Drug Target. 13 2005 73 80
34. L. Yang, X. Qi, P. Liu, A. El Ghzaoui, and S. Li Aggregation behavior of self-assembling polylactide/poly(ethylene glycol) micelles for sustained drug delivery Int. J. Pharm. 394 2010 43 49
35. A.L. van de Ven, P. Kim, M. Ferrari, and S.H. Yun Real-Time Intravital Microscopy of Individual Nanoparticle Dynamics in Liver and Tumors of Live Mice 2013 Protocol Exchange
36. X. Xu, X. Zhang, X. Wang, Y. Li, and X. Jing Comparative study of paclitaxel physically encapsulated in and chemically conjugated with PEG-PLA Polym. Adv. Technol. 20 2009 843 848
37. N. Rapoport, and K. Caldwell Structural transitions in micellar solutions of Pluronic P-105 and their effect on the conformation of dissolved cytochrome C: an electron paramagnetic resonance investigation Colloids Surf. B: Biointerfaces 3 1994 217 228
38. N. Rapoport Physical stimuli-responsive polymeric micelles for anti-cancer drug delivery Prog. Polym. Sci. 32 2007 962 990
39. N. Rapoport Ultrasound-mediated micellar drug delivery Int. J. Hyperth. 28 2012 374 385
40. M. Muniruzzaman, A. Marin, Y. Luo, G.D. Prestwich, W.G. Pitt, G. Husseini, and N.Y. Rapoport Intracellular uptake of Pluronic copolymer: effects of the aggregation state Colloids Surf. B: Biointerfaces 25 2002 233 241
41. N. Rapoport, A. Marin, Y. Luo, G.D. Prestwich, and M.D. Muniruzzaman Intracellular uptake and trafficking of Pluronic micelles in drug-sensitive and MDR cells: effect on the intracellular drug localization J. Pharm. Sci. 91 2002 157 170
42. L. Tang, A.L. van de Ven, D. Guo, V. Andasari, V. Cristini, K.C. Li, and X. Zhou Computational modeling of 3D tumor growth and angiogenesis for chemotherapy evaluation PLoS One 9 2014 e83962
43. M. Wu, H.B. Frieboes, S.R. McDougall, M.A. Chaplain, V. Cristini, and J. Lowengrub The effect of interstitial pressure on tumor growth: coupling with the blood and lymphatic vascular systems J. Theor. Biol. 320 2013 131 151
44. A. Gasselhuber, M.R. Dreher, F. Rattay, B.J. Wood, and D. Haemmerich Comparison of conventional chemotherapy, stealth liposomes and temperature-sensitive liposomes in a mathematical model PLoS One 7 2012 e47453
45. N.M. Emmanuel, and A.L. Buchachenko Chemical physics of polymer degradation and stabilization 1987 CRC Press
46. K.W. Ferrara Driving delivery vehicles with ultrasound Adv. Drug Deliv. Rev. 60 2008 1097 1102
47. M. McDermott, A.J. Eustace, S. Busschots, L. Breen, J. Crown, M. Clynes, N. O'Donovan, and B. Stordal In vitro development of chemotherapy and targeted therapy drug-resistant cancer cell lines: a practical guide with case studies Front. Oncol. 4 2014 40
48. L.E. van Vlerken, Z. Duan, S.R. Little, M.V. Seiden, and M.M. Amiji Biodistribution and pharmacokinetic analysis of paclitaxel and ceramide administered in multifunctional polymer-blend nanoparticles in drug resistant breast cancer model Mol. Pharm. 5 2008 516 526